Carotid Intima-media Thickness in Dialysis Patients and Traditional Risk Factors
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorMinia University
About this trial
* Cardiovascular disease (CVD) is the leading cause of mortality in hemodialysis (HD) patients. * Carotid intima-media thickness (CIMT) is a validated surrogate marker for atherosclerosis. * Both traditional cardiovascular risk factors (hypertension, diabetes, dyslipidemia) and dialysis-specific factors (mineral metabolism disorders, dialysis duration) contribute to vascular damage.
Eligibility criteria
Qualifiers
1. Age 18 or older. 2. Patients with sepsis without AKI at the time of admission.
Disqualifiers
o Active malignancy
Acute infections
Recent cardiovascular events (<3 months)
Poor echocardiographic window for CIMT measurement
Trial design
Treatments tested in this trial
- Ultrasound measurements of carotid intima- media thickness
Treatment groups
No treatment groups listed
Locations
This trial has no locations
Sponsors and collaborators
Minia University
Lead sponsor
Source ClinicalTrials.gov